Connect
MJA
MJA

Major haemorrhage in rural Australia: time for a novel solution to a unique problem?

Stuart A Gillon and Cem R Kibar
Med J Aust 2012; 196 (4): . || doi: 10.5694/mja11.11244
Published online: 5 March 2012

To the Editor: The past decade has seen significant change in the management of major haemorrhage, including earlier and more aggressive use of fresh frozen plasma (FFP). Australian guidelines now advocate high ratios of FFP to packed red blood cells (PRBC) from the outset of resuscitation.1 Preparation of one unit of FFP for every two units of PRBC is recommended. This approach is supported by a recent meta-analysis demonstrating a reduction in organ failure and mortality with high FFP : PRBC ratios.2


  • Royal Flying Doctor Service (Western Operations), Perth, WA.


Correspondence: sgillon@me.com

Acknowledgements: 

We acknowledge the assistance of the haematology specialists of the Australian Red Cross and Perth tertiary hospitals, including Dr Nicole Staples.

Competing interests:

No relevant disclosures.

  • 1. National Blood Authority Australia. Patient blood management guidelines: module 1. Critical bleeding/massive transfusion. Canberra: National Blood Authority, 2011. http://www.nba.gov.au/guidelines/module1/index.html#/guidelines/module1/cbmt.pdf (accessed Jan 2012).
  • 2. Murad MH, Stubbs JR, Gandhi MJ, et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 2010; 50: 1370-1383.
  • 3. Fatovich DM, Phillips M, Langford SA, Jacobs IG. A comparison of metropolitan vs rural major trauma in Western Australia. Resuscitation 2011; 82: 886-890.
  • 4. Schöchl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83.
  • 5. Shakur H, Roberts I, Bautista R, et al; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.